HLA-B5 prevalence in patients with spondyloarthritis and impact on disease phenotype: a multicentric case-control study.

Rheumatology (Oxford) · 2025 · PMC11962898 · PMID 39018174

Europe PMC DOI

hedged sentence

0.2300

closest p · 4.6× alpha

0.2300

boldest claim

The sentences

did not reach statistical significanceP = 0.230not close (p > 0.1)

Also, HLA-B52 was numerically more frequent in patients with SpA (8.1%) compared with HCs (4.2%), but the difference did not reach statistical significance ( P = 0.230).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.